Khalid AL. Naamani: Efficacy, Safety, and Patient Selection of DOACs in Cirrhosis
Khalid AL. Naamani, Executive Committee Member Ministry of Health Oman, Chairman of The Medical City for Military and Security Services, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I’m pleased to share our recent publication: Direct Oral Anticoagulants for Portal Vein Thrombosis in Cirrhosis: From Pharmacology to Clinical Practice
In this review, we explore the evolving role of direct oral anticoagulants (DOACs) in the management of portal vein thrombosis (PVT) in patients with cirrhosis.
Key highlights:
- Hemostasis in cirrhosis is a complex, rebalanced state rather than a simple bleeding tendency
- DOACs offer a promising alternative to traditional anticoagulants, with convenient fixed dosing and favorable safety profiles
- Evidence suggests comparable – and in some cases superior – recanalization rates versus VKAs, without a significant increase in major or variceal bleeding
- Careful patient selection remains essential, particularly based on liver function (CTP classification), renal status, and transplant candidacy
While current data are encouraging, further prospective studies are still needed, especially in patients with more advanced cirrhosis.
Grateful to my co-authors and collaborators for their valuable contributions to this work.”
Title: Direct Oral Anticoagulants for Portal Vein Thrombosis in Cirrhosis: From Pharmacology to Clinical Practice
Authors: Khalid M. Al Naamani, Sundus Rizwan, Siham Al Sinani, Bader Al Rawahi, Sheikha AlMa’mari, Mohamed El-Kassas
Read the Full Article on Clinical and Applied Thrombosis/Hemostasis
Stay updated on all scientific advances with Hemostasis Today.
-
May 16, 2026, 07:25Khurram Nasir: Preventive Cardiology Innovation and Scientific Dissemination at ESC 2026
-
May 15, 2026, 17:22Smbat Marukyan: How Inflamed Gums Can Lead to a Heart Attack – The Chain of Events
-
May 15, 2026, 17:20Ayman Arif: Understanding PRP Therapy in Aesthetic Medicine
-
May 15, 2026, 17:17Daniel Soffer: 2026 Dyslipidemia Guideline Pre-Proof Now Available Online
-
May 15, 2026, 17:14Alastair Lewis: Another The British Association of Sclerotherapists Annual Meeting Has Concluded
-
May 15, 2026, 17:12Uniting Global Partners to Transform Stroke Advocacy and Policy – International Journal of Stroke
-
May 15, 2026, 17:02Alyssa George: Anticoagulation Management During the Diagnostic Evaluation of HIT
-
May 15, 2026, 16:53Judeline Casimir: Preeclampsia Awareness Month – Moving From Knowing the Risks to Saving Lives
-
May 15, 2026, 16:51Muhammad Hashim Ali: A Clear Overview of Anemia and Its Mechanisms